Back to search

Article

Genetically-programmed Hypervesiculation of <i>Lactiplantibacillus plantarum</i> Increases Production of Bacterial Extracellular Vesicles with Therapeutic Efficacy in a Preclinical Inflammatory Bowel Disease Model

2025-06-25

Abstract excerpt

Inflammatory bowel diseases (IBD) affect over 6 million people globally and current treatments achieve only 10-20% rates of durable disease remission. Bacterial extracellular vesicles (BEVs) from probiotic lactic acid bacteria (LAB) are a promising novel therapeutic with mechanisms holding potential to drive increased rates of durable disease remission, including immunomodulation and intestinal epithelial tissue r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d3d0e401-8ad1-5b3d-a279-779b3cdadf89
DOI
10.1101/2025.06.20.660770
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetically-programmed Hypervesiculation of <i>Lactiplantibacillus plantarum</i> Increases Production of Bacterial Extracellular Vesicles with Therapeutic Efficacy in a Preclinical Inflammatory Bowel Disease ModelDOI 10.1101/2025.06.20.660770
Bletilla striata-derived extracellular vesicles armed probiotic by supramolecular assembly ameliorates colitis via macrophage modulation and microbiota restorationSemantic proximity
<i>Bifidobacterium longum</i> subsp <i>. longum</i> BG-L47 boosts growth and activity of <i>Limosilactobacillus reuteri</i> DSM 17938 and its extracellular membrane vesiclesSemantic proximity
Bio-engineering a common probiotic to exploit colonic inflammation promotes reliable efficacy in translational models of colitisSemantic proximity
Engineering a novel probiotic toolkit in <i>Escherichia coli Nissle1917</i> for sensing and mitigating gut inflammatory diseasesSemantic proximity
<i>Lactococcus lactis</i>as a live vector for mucosal delivery of therapeutic proteinsSemantic proximity
Genetically engineered bacteria as inflammatory bowel disease therapeuticsSemantic proximity
Extracellular vesicles produced by the human commensal gut bacterium <i>Bacteroides thetaiotaomicron</i> affect host immune pathways in a cell-type specific manner that are altered in inflammatory bowel diseaseSemantic proximity
Microbiota–host communications: Bacterial extracellular vesicles as a common languageSemantic proximity
Advancements in Lactiplantibacillus plantarum : probiotic characteristics, gene editing technologies and applicationsSemantic proximity
Modeling host-microbe interactions in immunocompetent engineered human gut tissuesSemantic proximity
Application of bacterial extracellular vesicles in gastrointestinal diseasesSemantic proximity
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus InfectionSemantic proximity
Select a neighboring publication to make it the new centre.